Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Capital Employed: 2016-2025

Historic Return on Capital Employed for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to -1.38%.

  • Editas Medicine's Return on Capital Employed fell 57.00% to -1.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.38%, marking a year-over-year decrease of 57.00%. This contributed to the annual value of -0.73% for FY2024, which is 35.00% down from last year.
  • Latest data reveals that Editas Medicine reported Return on Capital Employed of -1.38% as of Q3 2025, which was up 1.76% from -1.40% recorded in Q2 2025.
  • Editas Medicine's 5-year Return on Capital Employed high stood at -0.24% for Q1 2021, and its period low was -1.40% during Q2 2025.
  • In the last 3 years, Editas Medicine's Return on Capital Employed had a median value of -0.63% in 2024 and averaged -0.78%.
  • As far as peak fluctuations go, Editas Medicine's Return on Capital Employed climbed by 14bps in 2021, and later slumped by 77bps in 2025.
  • Over the past 5 years, Editas Medicine's Return on Capital Employed (Quarterly) stood at -0.30% in 2021, then declined by 19bps to -0.49% in 2022, then rose by 10bps to -0.39% in 2023, then crashed by 59bps to -0.98% in 2024, then crashed by 57bps to -1.38% in 2025.
  • Its last three reported values are -1.38% in Q3 2025, -1.40% for Q2 2025, and -1.13% during Q1 2025.